Record quarterly revenue of $78.1 million marked a 23.9% year-over-year increase, with strong growth in ventilator and PAP therapy patient counts. Adjusted EBITDA declined slightly due to a prior-year non-recurring gain, while full-year guidance was raised on continued momentum.Original document: V…
Record quarterly revenue of $78.1 million marked a 23.9% year-over-year increase, with strong growth in ventilator and PAP therapy patient counts. Adjusted EBITDA declined slightly due to a prior-year non-recurring gain, while full-year guidance was raised on continued momentum.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
